Updated Jul 16, 2026
Shannon James Samuel has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — buying. Lifetime open-market purchases: $44K.
Shannon James Samuel is associated with MannKind Corporation, a biopharmaceutical company focused on the development and commercialization of innovative therapies for diabetes and other endocrine disorders. Further details about their specific role or contributions to the company are not readily available.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-30 | XLO | Xilio Therapeutics, Inc. | P — Open-market purchase | 5.0K | $8.79 | $44K |
| 2026-03-04 | MNKD | MANNKIND CORP | A — Grant or award | 12.0K | $3.27 | $39K |
Shannon James Samuel is associated with MannKind Corporation, a biopharmaceutical company focused on the development and commercialization of innovative therapies for diabetes and other endocrine disorders. Further details about their specific role or contributions to the company are not readily available.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 1 open-market purchases ($44K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Shannon James Samuel profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.